« Au cœur des mécanismes de réponse et de régulation cellulaires »
L’Unité de Recherche en Biologie Cellulaire (URBC) comprend une quarantaine de chercheurs et techniciens qui étudient dans le domaine de la biologie cellulaire et moléculaire.
Les recherches sont consacrées à la compréhension des mécanismes de réponse cellulaire dans les situations normales et pathologiques.
Spotlight
News
Cellular "Velcro" Under Control
Cellular "Velcro" Under Control
How does the study of a cellular entry point shed light on certain mechanisms of cancer and viral infections?
Our skin, the lining of our intestines, and even our blood vessels are made up of cells organized into tissues. To stay in contact, communicate, and adapt their behavior, these cells rely in particular on proteins present on their surface. Among these, cell adhesion molecules play an essential role. Louise Thines, a researcher at the University of Namur and recipient of a Marie Skłodowska-Curie Actions (MSCA) grant, is studying how some of these proteins are internalized by cells, thereby reducing adhesion between them. This approach to understanding the mechanism offers avenues of research that are also relevant to the fight against cancer and viral infections.
A bioengineer, Louise Thines completed her dissertation in molecular and cellular biology at UCLouvain before continuing her research for three and a half years in Washington, D.C., in the United States. She then joined the University of Namur for a new postdoctoral fellowship in Professor Henri-François Renard’s laboratory, with support from MSCA funding.
"Velcro" on the surface of the cells?
In tissues, cells are constantly interacting with their neighbors and their environment. Certain proteins present in the cell membrane play a direct role in these interactions. This is the case with cell adhesion molecules, often referred to by the acronym CAMs.
These CAMs can be compared to tiny molecular Velcro fasteners that help keep cells in contact. They also play a role in transmitting signals into the cell and can influence the cell’s organization, movement, or interactions with neighboring cells. To control these interactions, the cell can add certain proteins to its membrane, move them, recycle them, or remove them. One of the mechanisms used to bring them into the cell is endocytosis.
CAMs play an important role in the ability of tissues to form, renew themselves, and repair themselves. During embryonic development or wound healing, for example, certain cells must modify their contacts with neighboring cells in order to change position and participate in tissue remodeling. By adjusting the adhesion molecules on their surfaces, they can strengthen certain contacts, loosen others, and become more mobile. This ability to modify intercellular adhesions is essential for the body’s normal functioning.
From Phagocytosis to Endocytosis
The process by which a cell takes in material (phagocytosis) was first described in the late 19th century by Élie Metchnikoff, a Russian zoologist working at the Pasteur Institute. Throughout the 20th century, extensive research led to the definition of the concept of endocytosis, which refers to the set of mechanisms involved in the internalization of particles. Today, research focuses on the molecular mechanisms underlying this phenomenon. A better understanding of a mechanism opens the door to developing tools or methods to control it for medical and pharmaceutical purposes.
Several entry points
During the process of endocytosis, the cell membrane bulges around a molecule on its surface. It gradually forms a pit that eventually closes off inside the cell, taking the form of a small vesicle.
Endocytosis can occur through several “pathways.” It’s a bit like a building with several types of doors operated by mechanisms that use different technologies.
The best-characterized pathway today involves a protein called clathrin, which, thanks to its structure, causes the cell membrane to curve inward until a vesicle is formed. But not all molecules follow this route.In 2020, research by Henri-François Renard revealed another endocytosis pathway. This pathway operates independently of clathrin and involves, in particular, endophilin-A3 to facilitate the entry of adhesion molecules into the cell.
It is this mechanism—which is still not fully understood—that lies at the heart of Louise’s project.
Why is this so important? Because in certain cancers, tumor cells can lose their ability to adhere, gain greater migratory capacity, and invade neighboring tissues. This process contributes to the various stages that can lead to the formation of metastases. Understanding how CAMs are removed or maintained on the cell surface therefore also provides insight into certain mechanisms associated with tumor progression. Furthermore, certain viruses can use CAMs as “Velcro” by attaching to them to gain entry into our cells. Targeting the CAM entry point could therefore be a promising strategy for combating certain viral diseases.
The ModulEndoA3 Project: Understanding How Cells Control Their Adhesion Sites
Louise is trying to determine how this endocytosis pathway works at the molecular level. Which molecules are involved? How do they interact? What triggers the internalization of an adhesion molecule into the cell? What happens when one of the components involved in this mechanism is disrupted?
In particular, Louise is studying the “Velcro” protein CD166, a cell adhesion molecule (CAM) found on the surface of various cells.
Observe the cells to take the machinery apart
To understand what is happening, Louise is working with human cancer cells grown in the laboratory.
She can modify the activity or abundance of proteins suspected of being involved in the mechanism, using genetic tools or chemical compounds. She then observes the consequences of these disruptions.
Microscopy plays a central role here. Using fluorescent markers, it becomes possible to visualize different proteins within the cells and track their location. Louise can thus simultaneously observe endophilin-A3 and the adhesion molecules that have been internalized into the cell’s cytoplasm.
The images serve not only to illustrate the experiment. They become data that the researcher can quantify and compare to determine whether an experimental modification accelerates, slows down, or disrupts endocytosis.
Hundreds of molecules were screened
To better understand the mechanisms of this endocytosis pathway, Louise is also seeking to identify other proteins that may be involved in its function.
In collaboration with the University of Geneva, she is testing hundreds of chemical compounds capable of affecting various proteins within the cell. After each treatment, images are automatically captured under a microscope to observe whether the endocytosis process is altered. Most of the compounds tested will likely have no particular effect. But if one of them significantly slows down or disrupts the mechanism, it is the protein it targets that becomes particularly interesting: it could be involved, directly or indirectly, in this endocytosis pathway. Further analyses are then needed to verify its role. These compounds are thus valuable tools for research. By blocking a protein and observing the consequences on the cell, researchers can gradually understand its function.
Certain molecules capable of modulating this pathway could also, in the longer term, open up avenues for new therapeutic strategies. At this stage, however, these are not yet drugs: between the identification of an active compound in cell culture and the development of a treatment, many research steps remain necessary.
Broadening Our Understanding of Endocytosis
Beyond its potential applications, Louise Thines’s project touches on a fundamental question in cell biology.
Traditional models have long been used to describe a few major pathways that cells use to internalize molecules on their surface. The discovery and study of clathrin-independent mechanisms now reveal a more diverse landscape. Understanding this diversity provides deeper insight into how a cell continuously regulates its interface with its environment and adapts its behavior.
The MSCA funding enables Louise to continue this exploration, develop new experimental approaches, and strengthen international collaborations. The results are expected, in particular, to help clarify the functioning of this endocytosis pathway and to identify new molecules capable of modulating it.
The Marie Skłodowska-Curie Fellowship (MSCA-PF)
The Marie Skłodowska-Curie Fellowship (MSCA-PF) is a selective European grant that enables a postdoctoral researcher to carry out an ambitious project at a new institution, often abroad. It supports the excellence of the project, the researcher’s mobility, and the development of their scientific career.
European Researchers' Night
To mark European Researchers’ Night, UNamur is highlighting several research projects conducted as part of the Marie Skłodowska-Curie Actions (MSCA). To make this research and its implications accessible to as many people as possible, Confluent des Savoirs—UNamur’s research outreach and dissemination service—has created a visual summary of each project. These visualizations aim to organize scientific information into illustrated, accessible summaries that combine keywords, diagrams, and graphics to help readers quickly grasp the mechanisms being studied and the key research questions.
These projects are part of the European Researchers’ Night initiative, which each year invites the public to discover research, the people behind it, and its role in our understanding of the world.
Carine Michiels awarded the SCK CEN "Roger Van Geen" Chair 2025
Carine Michiels awarded the SCK CEN "Roger Van Geen" Chair 2025
Created on the initiative of the Belgian Nuclear Research Center SCK CEN, this Chair is awarded every two years by the F.R.S.-FNRS and the FWO to recognize a leading researcher in the field of nuclear sciences and their applications. In 2025, the Chair will pay tribute to Carine Michiels' brilliant career and her outstanding contributions to radiobiology and cancer research.
Over the past two decades, Carine Michiels, professor of cell biology at UNamur and member of the radiobiology group at UNamur's life sciences research institute (NARILIS), has significantly advanced our understanding of the molecular mechanisms underlying the interaction between radiation and cancer cells. Within the Institute's cancer center, her research is based on a strong integration of cell biology and radiation physics, supported by a long-standing collaboration with the Institute's physicists, Professor Stéphane Lucas and Professor Anne-Catherine Heuskin. By bridging the gap between biology and physics, his team has conducted cutting-edge interdisciplinary research with the aim of improving the effectiveness of radiation therapy for cancer.
Preserving healthy cells
One of their main achievements is the development of innovative therapeutic approaches that combine advanced irradiation techniques, such as proton therapy, with unique nanohybrid compounds. These compounds, consisting of gold nanoparticles coupled with targeted antibodies, act as radiosensitizers, increasing the sensitivity of cancer cells to radiation while limiting damage to surrounding healthy tissue.
By paving the way for more precise and personalized cancer treatments, Carine Michiels' research is fully in line with the objectives of the SCK CEN Chair. Her achievements illustrate how fundamental research in radiation sciences can translate into significant advances in medicine and public health.
Long-standing collaborations
The University of Namur and SCK CEN have been collaborating for many years, notably through joint research projects and co-supervision of theses, including most recently that of Naomi Daems, for which Carine Michiels and Stéphane Lucas were co-supervisors alongside Professor Sarah Baatout (SCK CEN). Thanks to the latter, Carine Michiels joined the group of experts of the Belgian delegation to UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), an international UN committee set up to assess the effects of ionizing radiation on human health and the environment.
I would particularly like to thank my colleagues Sarah Baatout from SCK CEN, Stéphane Lucas and Anne-Catherine Heuskin from UNamur for their research collaboration. I would also like to thank Télévie from F.R.S.-FNRS and the strategic research project Proton Therapy Research in Wallonia (PROTHER-WAL) from SPW Recherche for their support!
A series of conferences in Mol
In addition to receiving a personal award, the SCK CEN Chair holder will give an inaugural lecture and a series of lectures for students, SCK CEN researchers, and the Belgian nuclear community in general during a scientific visit to the Research Center in Mol, Belgium. The series of lectures will be organized in collaboration with the SCK CEN Academy.
Namur Research Institute for Life Sciences (NARILIS)
NARILIS seeks to stimulate two-way interactions between basic researchers and clinicians, and to build bridges between the laboratory and the patient's bedside. NARILIS therefore aims to facilitate the translation of basic research findings into clinical applications. Its mission is to promote multidisciplinary research in order to improve human and animal health and quality of life.
Plants against steatotic liver disease, a HEPATANT project!
Plants against steatotic liver disease, a HEPATANT project!
At UNamur, research is not confined to laboratories. From physics to political science, robotics, biodiversity, law, AI, and health, researchers collaborate daily with numerous stakeholders in society. The goal? To transform ideas into concrete solutions to address current challenges.
Focus #1 | The HEPATANT project
HEPATANT is a project run by the Wagralim Competitiveness Cluster and coordinated by ORTIS Laboratories, a company that has been a pioneer in the field of phytosanitary products (plant-based dietary supplements) for 60 years. It aims to find a natural treatment for fatty liver disease. Several partners are involved in the project, including Professor Thierry Arnould (UNamur, URBC-Narilis).
Our metabolism naturally leads to the accumulation or synthesis of fat. Certain cells are designed for this purpose: these are called adipocytes. The main goal is to be able to mobilize fat and release fatty acids "when needed." The problem is that if there is an excess of nutrients, certain cells in the body, which are not designed to do so, can also accumulate fat in tissues such as the liver, heart, or muscles, which can cause health problems. This is known as "lipotoxicity."
Metabolic dysfunction-associated steatotic liver disease (MASLD) is an accumulation of fat in the liver linked to metabolic disorders associated with metabolic syndrome, obesity, diabetes, or excessive alcohol consumption. Initially, it is often asymptomatic but can progress to inflammation, fibrosis, cirrhosis, or even liver cancer. However, it is reversible in its early stages (steatosis). Treatment is based on weight loss, a healthy diet (reduced sugar/fat intake), and physical exercise, as few specific drugs have been approved by the FDA (Food and Drug Administration) at this time. Dietary supplements—based on plants known to be beneficial—are often used to treat this type of condition, but there is little or no scientific and mechanistic evidence on the actual effects of these products.
If the effectiveness of a dietary supplement or combination of supplements could be demonstrated, it would be possible to intervene at the primary stage of the condition and undoubtedly prevent this liver disorder, thereby halting or at least slowing its progression to advanced or even irreversible stages. This is the aim of this project, in which Professor Thierry Arnould was chosen for his expertise in lipid metabolism. Professor Arnould and postdoctoral researcher Célia Thomas are testing plant extracts (including hops) in vitro on fat-laden cells to investigate the effects that increase or decrease lipid accumulation.
The originality and feasibility of the project lie in the alliance of scientific experts internationally recognized for their expertise in biomedical and pharmaceutical sciences, and in technological and agronomic sciences, with renowned industrialists in their field of expertise related to the project's needs.
In addition to its main objective of creating an effective formulation against hepatic steatosis by combining the best plants or plant substances, this project also aims to generate economic growth, create and sustain jobs in Wallonia, and contribute to the international reputation of the Walloon partner universities: UCLouvain and UNamur.
The partners of the HEPATANT project
- Prof. Thierry Arnould – UNamur, URBC, Narilis | Expertise: The URBC-NARILIS laboratory has extensive expertise and experience in cell differentiation, metabolism, and lipid metabolism in obesity and adipose cells. It also has excellent expertise in the field of hepatocytes and hepatogenic differentiation from precursors and stem cells (collaboration with Professor P. Renard, UNamur, URBC-NARILIS).
- Prof. Isabelle Leclercq - UCLouvain (IREC/GAEN) | Expertise: Pathogenesis of liver diseases in in vivo models.
- Remi Desmet – UCLouvain (Louvain University Farms - FERM) | Expertise: Agronomic research - As a UCLouvain technology platform, FERM works with farmers and partners to support the transition to more sustainable agricultural models.
- Alexandre Dumont de Chassart - Yakima Chief Hops | Expertise: Production of hops and hop-derived products.
- Caroline Devillers – Bel go Bio | Expertise: Agricultural cooperative
Competitiveness Clusters in the Walloon Region
Since their creation in 2006, competitiveness clusters have brought together companies, accredited research centers, and universities around ambitious collaborative projects. Supported and funded by the Walloon Region to stimulate innovation and economic growth, competitiveness cluster projects are organized around six strategic sectors: biotechnology (BioWin), aerospace (SkyWin Wallonia), logistics (Logistics in Wallonia), green chemistry (GreenWin), mechanical engineering (Mecatech), and food system transition (Wagralim). aerospace (SkyWin Wallonia), logistics (Logistics in Wallonia), green chemistry (GreenWin), mechanical engineering (Mecatech), and food system transition (Wagralim).
The projects aim to develop innovative products, services, or processes, creating jobs and strengthening international competitiveness. UNamur is heavily involved in these projects.
Wagralim, the Walloon agri-food cluster, has more than 300 members working to stimulate innovation and collaboration within the food ecosystem and support stakeholders in their responsible development and sustainable transition.
From fundamental to applied research, UNamur demonstrates every day that research is a driver of transformation. Thanks to the commitment of its researchers, the support of its partners from all walks of life, funders, industrial partners, and a solid ecosystem of valorization, UNamur actively participates in shaping a society that is open to the world, more innovative, more responsible, and more sustainable.
To go further
This article complements our publication "Research and innovation: major assets for the industrial sector" taken from the Issues section of Omalius magazine #39 (December 2025).
21 new F.R.S.-FNRS grants for research at UNamur
21 new F.R.S.-FNRS grants for research at UNamur
The F.R.S.-FNRS has just published the results of its various 2024 calls. Equipment calls, research credits and projects, FRIA doctoral grants and Mandant d'Impulsion Scientifique (MIS), there are many instruments to support fundamental research. Find out more about UNamur's results.
The "research credits and projects" call resulted in 14 grants for ambitious new projects. These include two "equipment" grants, five "research credits (CDR)" grants and seven "research projects (PDR)" grants, including one in collaboration with the University of Applied Sciences and Arts of Western Switzerland. The FRIA doctoral research support call will fund 6 doctoral fellowships.
A prestigious Mandat d'Impulsion Scientifique (MIS) has also been obtained. This 3-year funding supports young permanent researchers wishing to develop an original and innovative research program while acquiring scientific autonomy within their department.
Results in detail
Call for Equipment
- Max Collinet, Institut ILEE
- Catherine Michaux, with Stéphane Vincent and Guillaume Berionni, co-sponsors, Institut NISM
Call for Research Credits (CDR)
- Thierry Arnould, Institut NARILIS
- Thomas Balligand, Department of Medicine
- Danielle Leenaerts, Institut PaTHs
- Denis Saint-Amand, Institut NaLTT
- Elio Tuci, Institut NADI
Appel Projets de Recherche (PDR)
- Nathalie Burnay, in collaboration with "the University of Applied Sciences and Arts of Western Switzerland", Institut Transitions (Subject to acceptance by SNSF Switzerland)
- Catherine Guirkinger, Institut DEFIPP, co-promoter in collaboration with UCLouvain
- Luca Fusaro, Institut NISM
- Laurence Meurant, Institut NaLTT
- René Preys, Institut PaTHs
- Stéphane Vincent, Institut NISM, co-promoter in collaboration with UCLouvain
- Johan Wouters, Institut NISM, co-promoter in collaboration with UCLouvain
Fonds pour la formation à la Recherche dans l'Industrie et dans l'Agriculture (FRIA)
- Alix Buridant - Promoter: Henri-François Renard, Institut NARILIS ; Co-sponsor: Medical University of Innsbruck, Innsbruck - Austria -
- Constance De Maere d'Aertrycke - Promoter Nicolas Gillet, Institut NARILIS
- Noah Deveaux - Promoter: Benoît Champagne, Institut NISM
- Nicolas Dricot - Promoter: Muriel Lepère, Institut NISM; Co-promoter: Bastien Vispoel, Institut NISM and Université Grenoble Alpes
- Laurie Marchal - Promoter Thierry Arnould. Co-promoter: Patricia Renard. Institut NARILIS
- Léa Poskin - Promoter: Catherine Michaux, Institut NISM; Co-promoter: Jean-Pierre Gillet, Institut NARILIS
Mandat d'Impulsion Scientifique (MIS)
- Arthur Borriello, Institut Transitions
Congratulations to all and sundry
!F.R.S.-FNRS missions
The mission of the Fonds de la Recherche Scientifique - FNRS is to develop basic scientific research through initiatives presented by researchers. It promotes the production and development of knowledge by supporting individual researchers on the one hand, and by financing research programs carried out in laboratories and departments located mainly in the universities of the Wallonia-Brussels Federation on the other.
Based on the sole criterion of scientific excellence, financial support from the F.R.S.-FNRS is provided in several ways. Numerous calls for funding are launched each year to support fundamental research at all levels of researchers' careers.
Cellular "Velcro" Under Control
Cellular "Velcro" Under Control
How does the study of a cellular entry point shed light on certain mechanisms of cancer and viral infections?
Our skin, the lining of our intestines, and even our blood vessels are made up of cells organized into tissues. To stay in contact, communicate, and adapt their behavior, these cells rely in particular on proteins present on their surface. Among these, cell adhesion molecules play an essential role. Louise Thines, a researcher at the University of Namur and recipient of a Marie Skłodowska-Curie Actions (MSCA) grant, is studying how some of these proteins are internalized by cells, thereby reducing adhesion between them. This approach to understanding the mechanism offers avenues of research that are also relevant to the fight against cancer and viral infections.
A bioengineer, Louise Thines completed her dissertation in molecular and cellular biology at UCLouvain before continuing her research for three and a half years in Washington, D.C., in the United States. She then joined the University of Namur for a new postdoctoral fellowship in Professor Henri-François Renard’s laboratory, with support from MSCA funding.
"Velcro" on the surface of the cells?
In tissues, cells are constantly interacting with their neighbors and their environment. Certain proteins present in the cell membrane play a direct role in these interactions. This is the case with cell adhesion molecules, often referred to by the acronym CAMs.
These CAMs can be compared to tiny molecular Velcro fasteners that help keep cells in contact. They also play a role in transmitting signals into the cell and can influence the cell’s organization, movement, or interactions with neighboring cells. To control these interactions, the cell can add certain proteins to its membrane, move them, recycle them, or remove them. One of the mechanisms used to bring them into the cell is endocytosis.
CAMs play an important role in the ability of tissues to form, renew themselves, and repair themselves. During embryonic development or wound healing, for example, certain cells must modify their contacts with neighboring cells in order to change position and participate in tissue remodeling. By adjusting the adhesion molecules on their surfaces, they can strengthen certain contacts, loosen others, and become more mobile. This ability to modify intercellular adhesions is essential for the body’s normal functioning.
From Phagocytosis to Endocytosis
The process by which a cell takes in material (phagocytosis) was first described in the late 19th century by Élie Metchnikoff, a Russian zoologist working at the Pasteur Institute. Throughout the 20th century, extensive research led to the definition of the concept of endocytosis, which refers to the set of mechanisms involved in the internalization of particles. Today, research focuses on the molecular mechanisms underlying this phenomenon. A better understanding of a mechanism opens the door to developing tools or methods to control it for medical and pharmaceutical purposes.
Several entry points
During the process of endocytosis, the cell membrane bulges around a molecule on its surface. It gradually forms a pit that eventually closes off inside the cell, taking the form of a small vesicle.
Endocytosis can occur through several “pathways.” It’s a bit like a building with several types of doors operated by mechanisms that use different technologies.
The best-characterized pathway today involves a protein called clathrin, which, thanks to its structure, causes the cell membrane to curve inward until a vesicle is formed. But not all molecules follow this route.In 2020, research by Henri-François Renard revealed another endocytosis pathway. This pathway operates independently of clathrin and involves, in particular, endophilin-A3 to facilitate the entry of adhesion molecules into the cell.
It is this mechanism—which is still not fully understood—that lies at the heart of Louise’s project.
Why is this so important? Because in certain cancers, tumor cells can lose their ability to adhere, gain greater migratory capacity, and invade neighboring tissues. This process contributes to the various stages that can lead to the formation of metastases. Understanding how CAMs are removed or maintained on the cell surface therefore also provides insight into certain mechanisms associated with tumor progression. Furthermore, certain viruses can use CAMs as “Velcro” by attaching to them to gain entry into our cells. Targeting the CAM entry point could therefore be a promising strategy for combating certain viral diseases.
The ModulEndoA3 Project: Understanding How Cells Control Their Adhesion Sites
Louise is trying to determine how this endocytosis pathway works at the molecular level. Which molecules are involved? How do they interact? What triggers the internalization of an adhesion molecule into the cell? What happens when one of the components involved in this mechanism is disrupted?
In particular, Louise is studying the “Velcro” protein CD166, a cell adhesion molecule (CAM) found on the surface of various cells.
Observe the cells to take the machinery apart
To understand what is happening, Louise is working with human cancer cells grown in the laboratory.
She can modify the activity or abundance of proteins suspected of being involved in the mechanism, using genetic tools or chemical compounds. She then observes the consequences of these disruptions.
Microscopy plays a central role here. Using fluorescent markers, it becomes possible to visualize different proteins within the cells and track their location. Louise can thus simultaneously observe endophilin-A3 and the adhesion molecules that have been internalized into the cell’s cytoplasm.
The images serve not only to illustrate the experiment. They become data that the researcher can quantify and compare to determine whether an experimental modification accelerates, slows down, or disrupts endocytosis.
Hundreds of molecules were screened
To better understand the mechanisms of this endocytosis pathway, Louise is also seeking to identify other proteins that may be involved in its function.
In collaboration with the University of Geneva, she is testing hundreds of chemical compounds capable of affecting various proteins within the cell. After each treatment, images are automatically captured under a microscope to observe whether the endocytosis process is altered. Most of the compounds tested will likely have no particular effect. But if one of them significantly slows down or disrupts the mechanism, it is the protein it targets that becomes particularly interesting: it could be involved, directly or indirectly, in this endocytosis pathway. Further analyses are then needed to verify its role. These compounds are thus valuable tools for research. By blocking a protein and observing the consequences on the cell, researchers can gradually understand its function.
Certain molecules capable of modulating this pathway could also, in the longer term, open up avenues for new therapeutic strategies. At this stage, however, these are not yet drugs: between the identification of an active compound in cell culture and the development of a treatment, many research steps remain necessary.
Broadening Our Understanding of Endocytosis
Beyond its potential applications, Louise Thines’s project touches on a fundamental question in cell biology.
Traditional models have long been used to describe a few major pathways that cells use to internalize molecules on their surface. The discovery and study of clathrin-independent mechanisms now reveal a more diverse landscape. Understanding this diversity provides deeper insight into how a cell continuously regulates its interface with its environment and adapts its behavior.
The MSCA funding enables Louise to continue this exploration, develop new experimental approaches, and strengthen international collaborations. The results are expected, in particular, to help clarify the functioning of this endocytosis pathway and to identify new molecules capable of modulating it.
The Marie Skłodowska-Curie Fellowship (MSCA-PF)
The Marie Skłodowska-Curie Fellowship (MSCA-PF) is a selective European grant that enables a postdoctoral researcher to carry out an ambitious project at a new institution, often abroad. It supports the excellence of the project, the researcher’s mobility, and the development of their scientific career.
European Researchers' Night
To mark European Researchers’ Night, UNamur is highlighting several research projects conducted as part of the Marie Skłodowska-Curie Actions (MSCA). To make this research and its implications accessible to as many people as possible, Confluent des Savoirs—UNamur’s research outreach and dissemination service—has created a visual summary of each project. These visualizations aim to organize scientific information into illustrated, accessible summaries that combine keywords, diagrams, and graphics to help readers quickly grasp the mechanisms being studied and the key research questions.
These projects are part of the European Researchers’ Night initiative, which each year invites the public to discover research, the people behind it, and its role in our understanding of the world.
Carine Michiels awarded the SCK CEN "Roger Van Geen" Chair 2025
Carine Michiels awarded the SCK CEN "Roger Van Geen" Chair 2025
Created on the initiative of the Belgian Nuclear Research Center SCK CEN, this Chair is awarded every two years by the F.R.S.-FNRS and the FWO to recognize a leading researcher in the field of nuclear sciences and their applications. In 2025, the Chair will pay tribute to Carine Michiels' brilliant career and her outstanding contributions to radiobiology and cancer research.
Over the past two decades, Carine Michiels, professor of cell biology at UNamur and member of the radiobiology group at UNamur's life sciences research institute (NARILIS), has significantly advanced our understanding of the molecular mechanisms underlying the interaction between radiation and cancer cells. Within the Institute's cancer center, her research is based on a strong integration of cell biology and radiation physics, supported by a long-standing collaboration with the Institute's physicists, Professor Stéphane Lucas and Professor Anne-Catherine Heuskin. By bridging the gap between biology and physics, his team has conducted cutting-edge interdisciplinary research with the aim of improving the effectiveness of radiation therapy for cancer.
Preserving healthy cells
One of their main achievements is the development of innovative therapeutic approaches that combine advanced irradiation techniques, such as proton therapy, with unique nanohybrid compounds. These compounds, consisting of gold nanoparticles coupled with targeted antibodies, act as radiosensitizers, increasing the sensitivity of cancer cells to radiation while limiting damage to surrounding healthy tissue.
By paving the way for more precise and personalized cancer treatments, Carine Michiels' research is fully in line with the objectives of the SCK CEN Chair. Her achievements illustrate how fundamental research in radiation sciences can translate into significant advances in medicine and public health.
Long-standing collaborations
The University of Namur and SCK CEN have been collaborating for many years, notably through joint research projects and co-supervision of theses, including most recently that of Naomi Daems, for which Carine Michiels and Stéphane Lucas were co-supervisors alongside Professor Sarah Baatout (SCK CEN). Thanks to the latter, Carine Michiels joined the group of experts of the Belgian delegation to UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), an international UN committee set up to assess the effects of ionizing radiation on human health and the environment.
I would particularly like to thank my colleagues Sarah Baatout from SCK CEN, Stéphane Lucas and Anne-Catherine Heuskin from UNamur for their research collaboration. I would also like to thank Télévie from F.R.S.-FNRS and the strategic research project Proton Therapy Research in Wallonia (PROTHER-WAL) from SPW Recherche for their support!
A series of conferences in Mol
In addition to receiving a personal award, the SCK CEN Chair holder will give an inaugural lecture and a series of lectures for students, SCK CEN researchers, and the Belgian nuclear community in general during a scientific visit to the Research Center in Mol, Belgium. The series of lectures will be organized in collaboration with the SCK CEN Academy.
Namur Research Institute for Life Sciences (NARILIS)
NARILIS seeks to stimulate two-way interactions between basic researchers and clinicians, and to build bridges between the laboratory and the patient's bedside. NARILIS therefore aims to facilitate the translation of basic research findings into clinical applications. Its mission is to promote multidisciplinary research in order to improve human and animal health and quality of life.
Plants against steatotic liver disease, a HEPATANT project!
Plants against steatotic liver disease, a HEPATANT project!
At UNamur, research is not confined to laboratories. From physics to political science, robotics, biodiversity, law, AI, and health, researchers collaborate daily with numerous stakeholders in society. The goal? To transform ideas into concrete solutions to address current challenges.
Focus #1 | The HEPATANT project
HEPATANT is a project run by the Wagralim Competitiveness Cluster and coordinated by ORTIS Laboratories, a company that has been a pioneer in the field of phytosanitary products (plant-based dietary supplements) for 60 years. It aims to find a natural treatment for fatty liver disease. Several partners are involved in the project, including Professor Thierry Arnould (UNamur, URBC-Narilis).
Our metabolism naturally leads to the accumulation or synthesis of fat. Certain cells are designed for this purpose: these are called adipocytes. The main goal is to be able to mobilize fat and release fatty acids "when needed." The problem is that if there is an excess of nutrients, certain cells in the body, which are not designed to do so, can also accumulate fat in tissues such as the liver, heart, or muscles, which can cause health problems. This is known as "lipotoxicity."
Metabolic dysfunction-associated steatotic liver disease (MASLD) is an accumulation of fat in the liver linked to metabolic disorders associated with metabolic syndrome, obesity, diabetes, or excessive alcohol consumption. Initially, it is often asymptomatic but can progress to inflammation, fibrosis, cirrhosis, or even liver cancer. However, it is reversible in its early stages (steatosis). Treatment is based on weight loss, a healthy diet (reduced sugar/fat intake), and physical exercise, as few specific drugs have been approved by the FDA (Food and Drug Administration) at this time. Dietary supplements—based on plants known to be beneficial—are often used to treat this type of condition, but there is little or no scientific and mechanistic evidence on the actual effects of these products.
If the effectiveness of a dietary supplement or combination of supplements could be demonstrated, it would be possible to intervene at the primary stage of the condition and undoubtedly prevent this liver disorder, thereby halting or at least slowing its progression to advanced or even irreversible stages. This is the aim of this project, in which Professor Thierry Arnould was chosen for his expertise in lipid metabolism. Professor Arnould and postdoctoral researcher Célia Thomas are testing plant extracts (including hops) in vitro on fat-laden cells to investigate the effects that increase or decrease lipid accumulation.
The originality and feasibility of the project lie in the alliance of scientific experts internationally recognized for their expertise in biomedical and pharmaceutical sciences, and in technological and agronomic sciences, with renowned industrialists in their field of expertise related to the project's needs.
In addition to its main objective of creating an effective formulation against hepatic steatosis by combining the best plants or plant substances, this project also aims to generate economic growth, create and sustain jobs in Wallonia, and contribute to the international reputation of the Walloon partner universities: UCLouvain and UNamur.
The partners of the HEPATANT project
- Prof. Thierry Arnould – UNamur, URBC, Narilis | Expertise: The URBC-NARILIS laboratory has extensive expertise and experience in cell differentiation, metabolism, and lipid metabolism in obesity and adipose cells. It also has excellent expertise in the field of hepatocytes and hepatogenic differentiation from precursors and stem cells (collaboration with Professor P. Renard, UNamur, URBC-NARILIS).
- Prof. Isabelle Leclercq - UCLouvain (IREC/GAEN) | Expertise: Pathogenesis of liver diseases in in vivo models.
- Remi Desmet – UCLouvain (Louvain University Farms - FERM) | Expertise: Agronomic research - As a UCLouvain technology platform, FERM works with farmers and partners to support the transition to more sustainable agricultural models.
- Alexandre Dumont de Chassart - Yakima Chief Hops | Expertise: Production of hops and hop-derived products.
- Caroline Devillers – Bel go Bio | Expertise: Agricultural cooperative
Competitiveness Clusters in the Walloon Region
Since their creation in 2006, competitiveness clusters have brought together companies, accredited research centers, and universities around ambitious collaborative projects. Supported and funded by the Walloon Region to stimulate innovation and economic growth, competitiveness cluster projects are organized around six strategic sectors: biotechnology (BioWin), aerospace (SkyWin Wallonia), logistics (Logistics in Wallonia), green chemistry (GreenWin), mechanical engineering (Mecatech), and food system transition (Wagralim). aerospace (SkyWin Wallonia), logistics (Logistics in Wallonia), green chemistry (GreenWin), mechanical engineering (Mecatech), and food system transition (Wagralim).
The projects aim to develop innovative products, services, or processes, creating jobs and strengthening international competitiveness. UNamur is heavily involved in these projects.
Wagralim, the Walloon agri-food cluster, has more than 300 members working to stimulate innovation and collaboration within the food ecosystem and support stakeholders in their responsible development and sustainable transition.
From fundamental to applied research, UNamur demonstrates every day that research is a driver of transformation. Thanks to the commitment of its researchers, the support of its partners from all walks of life, funders, industrial partners, and a solid ecosystem of valorization, UNamur actively participates in shaping a society that is open to the world, more innovative, more responsible, and more sustainable.
To go further
This article complements our publication "Research and innovation: major assets for the industrial sector" taken from the Issues section of Omalius magazine #39 (December 2025).
21 new F.R.S.-FNRS grants for research at UNamur
21 new F.R.S.-FNRS grants for research at UNamur
The F.R.S.-FNRS has just published the results of its various 2024 calls. Equipment calls, research credits and projects, FRIA doctoral grants and Mandant d'Impulsion Scientifique (MIS), there are many instruments to support fundamental research. Find out more about UNamur's results.
The "research credits and projects" call resulted in 14 grants for ambitious new projects. These include two "equipment" grants, five "research credits (CDR)" grants and seven "research projects (PDR)" grants, including one in collaboration with the University of Applied Sciences and Arts of Western Switzerland. The FRIA doctoral research support call will fund 6 doctoral fellowships.
A prestigious Mandat d'Impulsion Scientifique (MIS) has also been obtained. This 3-year funding supports young permanent researchers wishing to develop an original and innovative research program while acquiring scientific autonomy within their department.
Results in detail
Call for Equipment
- Max Collinet, Institut ILEE
- Catherine Michaux, with Stéphane Vincent and Guillaume Berionni, co-sponsors, Institut NISM
Call for Research Credits (CDR)
- Thierry Arnould, Institut NARILIS
- Thomas Balligand, Department of Medicine
- Danielle Leenaerts, Institut PaTHs
- Denis Saint-Amand, Institut NaLTT
- Elio Tuci, Institut NADI
Appel Projets de Recherche (PDR)
- Nathalie Burnay, in collaboration with "the University of Applied Sciences and Arts of Western Switzerland", Institut Transitions (Subject to acceptance by SNSF Switzerland)
- Catherine Guirkinger, Institut DEFIPP, co-promoter in collaboration with UCLouvain
- Luca Fusaro, Institut NISM
- Laurence Meurant, Institut NaLTT
- René Preys, Institut PaTHs
- Stéphane Vincent, Institut NISM, co-promoter in collaboration with UCLouvain
- Johan Wouters, Institut NISM, co-promoter in collaboration with UCLouvain
Fonds pour la formation à la Recherche dans l'Industrie et dans l'Agriculture (FRIA)
- Alix Buridant - Promoter: Henri-François Renard, Institut NARILIS ; Co-sponsor: Medical University of Innsbruck, Innsbruck - Austria -
- Constance De Maere d'Aertrycke - Promoter Nicolas Gillet, Institut NARILIS
- Noah Deveaux - Promoter: Benoît Champagne, Institut NISM
- Nicolas Dricot - Promoter: Muriel Lepère, Institut NISM; Co-promoter: Bastien Vispoel, Institut NISM and Université Grenoble Alpes
- Laurie Marchal - Promoter Thierry Arnould. Co-promoter: Patricia Renard. Institut NARILIS
- Léa Poskin - Promoter: Catherine Michaux, Institut NISM; Co-promoter: Jean-Pierre Gillet, Institut NARILIS
Mandat d'Impulsion Scientifique (MIS)
- Arthur Borriello, Institut Transitions
Congratulations to all and sundry
!F.R.S.-FNRS missions
The mission of the Fonds de la Recherche Scientifique - FNRS is to develop basic scientific research through initiatives presented by researchers. It promotes the production and development of knowledge by supporting individual researchers on the one hand, and by financing research programs carried out in laboratories and departments located mainly in the universities of the Wallonia-Brussels Federation on the other.
Based on the sole criterion of scientific excellence, financial support from the F.R.S.-FNRS is provided in several ways. Numerous calls for funding are launched each year to support fundamental research at all levels of researchers' careers.
Agenda
Public Defense of a Doctoral Dissertation in Biological Sciences - Karim Bouhjar
A Study of Treatment-Induced Senescence (TIS) in Head and Neck Squamous Cell Carcinoma (HNSCC) According to HPV Status.
Abstract
Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous malignancy in which human papillomavirus (HPV) status strongly influences therapeutic response. HPV-positive tumors generally show greater sensitivity to treatment, whereas HPV-negative tumors are associated with a poorer prognosis and increased resistance. This thesis investigated how HPV status shapes cellular adaptation to therapeutic stress, with a particular focus on therapy-induced senescence (TIS), autophagy, and MMS19.
HPV- HNSCC cells developed a senescence-like phenotype following cisplatin or X-ray irradiation, whereas HPV+ cells showed limited induction. Silencing of the viral oncogenes E6 and E7 in HPV-positive cells enhanced this phenotype, indicating that HPV actively modulates treatment-induced cellular responses. Proteomic analyses further identified autophagy- and lysosome-related pathways as major features distinguishing HPV- from HPV+ cells. Autophagy inhibition predominantly impaired proliferation and clonogenic survival in HPV- cells, supporting an HPV-dependent autophagy–senescence axis involved in treatment adaptation.
The second part of this thesis identified MMS19, a component of the cytosolic iron–sulfur cluster assembly machinery, as a potential determinant of HPV- HNSCC resistance. MMS19 was associated with poorer clinical outcomes, while its silencing impaired proliferation and clonogenic survival, particularly in HPV- cells.
Together, these findings identify autophagy-dependent remodeling and MMS19-associated genome maintenance as potential vulnerabilities contributing to therapeutic resistance in HPV- HNSCC.
Jury
- Prof. Anne-Catherine HEUSKIN (UNamur), Chair
- Prof. Carine MICHIELS (UNamur), Secretary
- Prof. Francis RODIER (UMontreal)
- Prof. Yves POUMAY (UNamur)
- Prof. Anabelle DECOTTIGNIES (UCLouvain)
- Prof. Marc THERRIEN (University of Montreal)
- Prof. Sue YOM (UCSF)
Equipement et laboratoires
Outre l'équipement propre à l'unité, nous avons la chance de travailler avec 2 plateformes scientifiques qui nous aident dans nos analyses.
En savoir plus sur l'URBC
Nos bailleurs de fonds